COMMISSION DELEGATED REGULATION (EU) 2015/35 | 32015R0035 — European Union law | Esheria

COMMISSION DELEGATED REGULATION (EU) 2015/35

This segment is the table of contents and recitals for the Solvency II delegated regulation, covering valuation, capital requirements, governance, reporting, group supervision, and third-country equivalence.

AI-assisted research synopsis — verify against the official legal text below.

Jurisdiction
European Union
Instrument
Regulation
Citation
32015R0035
Status
In force
Version
Undated source snapshot
Language
en
Official source
View official record ↗
Solvency Capital Requirement ancillary own funds annex tables asset valuation capital add-ons capital calculation capital management capital requirements catastrophe risk coordination arrangements counterparty default risk credit assessments currency risk data requirements due diligence earthquake risk equity risk financial reporting flood risk correlation matrices governance governance disclosure group solvency group supervision hail risk +41 more

Statute overview

About this statute

This segment is the table of contents and recitals for the Solvency II delegated regulation, covering valuation, capital requirements, governance, reporting, group supervision, and third-country equivalence. Insurance and reinsurance undertakings must manage internal-model data transparently, follow several governance and reporting duties, and may invest in securitisation positions only if the originator, sponsor or original lender retains a material net economic interest. This provision defines several terms and sets valuation, credit-assessment, and technical-provisions rules for insurance and reinsurance undertakings. This part sets rules for how insurance and reinsurance undertakings calculate technical provisions, best estimates, risk margin, recoverables, and related interest-rate inputs, and it also sets out what supervisory authorities must consider for ancillary own funds. This provision gives supervisory authorities powers and duties for assessing own funds, recoverability, and approvals, and it sets limits on certain own-fund treatments.